| scholarly article | Q13442814 |
| P50 | author | Jennifer Wargo | Q32650026 |
| Carlos Fernández-del Castillo | Q40930249 | ||
| P2093 | author name string | Andrew L Warshaw | |
| Cristina R Ferrone | |||
| Camilo Correa-Gallego | |||
| Sarah P Thayer | |||
| P2860 | cites work | Fluid CEA in IPMNs: A useful test or the flip of a coin? | Q51815698 |
| A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients | Q57823607 | ||
| Prevalence of unsuspected pancreatic cysts on MDCT | Q24650018 | ||
| Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients | Q35494053 | ||
| International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas | Q36331064 | ||
| Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas | Q37223256 | ||
| Current trends in pancreatic cystic neoplasms | Q37249696 | ||
| Pancreatic imaging: current state of the art. | Q37376961 | ||
| Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance? | Q44801640 | ||
| Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection | Q50149608 | ||
| P433 | issue | 2-3 | |
| P921 | main subject | cyst | Q193211 |
| P304 | page(s) | 144-150 | |
| P577 | publication date | 2010-05-17 | |
| P1433 | published in | Pancreatology | Q15750271 |
| P1476 | title | Incidental pancreatic cysts: do we really know what we are watching? | |
| P478 | volume | 10 |
| Q34994302 | A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas |
| Q37720426 | A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating? |
| Q39478886 | Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas. |
| Q37402106 | Analysis of clinical characteristics and treatment of pancreatic cystic tumors |
| Q42323569 | Asymptomatic pancreatic lesions: new insights and clinical implications. |
| Q37346558 | Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas |
| Q50737401 | Comparison of preoperative conference-based diagnosis with histology of cystic tumors of the pancreas. |
| Q37279909 | Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts |
| Q36699293 | Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms |
| Q48124066 | Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? |
| Q64108315 | Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions: 2017 Consensus Recommendations of the Korean Society of Abdominal Radiology |
| Q34158720 | Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts |
| Q92016029 | Differential diagnosis of pancreatic serous cystadenoma and mucinous cystadenoma: utility of textural features in combination with morphological characteristics |
| Q37104275 | Diffusion-Weighted Magnetic Resonance Imaging in Distinguishing Between Mucin-Producing and Serous Pancreatic Cysts. |
| Q45910710 | Does preoperative cross-sectional imaging accurately predict main duct involvement in intraductal papillary mucinous neoplasm? |
| Q52581137 | EUS-FNA in cystic pancreatic lesions: Where are we now and where are we headed in the future? |
| Q38647344 | Editorial: Management of the Small Asymptomatic Pancreatic Cyst: Somehow Along the Way We Forgot About the Patient |
| Q36315824 | Endoscopic ultrasonography evaluation for pancreatic cysts: Necessity or overkill? |
| Q60046413 | Endoscopic ultrasound-guided through-the-needle microforceps biopsy in the evaluation of pancreatic cystic lesions: a multicenter study |
| Q35179268 | Endosonography in the diagnosis and management of pancreatic cysts |
| Q37373098 | Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology. |
| Q48344329 | Fate of small pancreatic cysts (<3 cm) after long-term follow-up: analysis of significant radiologic characteristics and proposal of follow-up strategies |
| Q39622483 | Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms |
| Q55382636 | Future Perspectives on Endoscopic Ultrasonography-Guided Therapy for Pancreatic Neoplasm. |
| Q37589841 | GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs". |
| Q92154767 | Genetic testing vs microforceps biopsy in pancreatic cysts: Systematic review and meta-analysis |
| Q46867228 | Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts |
| Q38133749 | IPMN: surgical treatment |
| Q34438494 | Imaging patterns of intraductal papillary mucinous neoplasms of the pancreas: an illustrated discussion of the International Consensus Guidelines for the Management of IPMN. |
| Q38147548 | Improvement of surgical results for pancreatic cancer |
| Q35732309 | In vivo risk analysis of pancreatic cancer through optical characterization of duodenal mucosa |
| Q88028082 | Incidental Cystic Lesions in the Pancreas: Resect? EUS? Follow? |
| Q37176504 | Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines |
| Q37549842 | Investigating MicroRNA Expression Profiles in Pancreatic Cystic Neoplasms |
| Q46540266 | Lymphangioma of the pancreas: a multimodal approach to pre-operative diagnosis |
| Q26796503 | Management of Incidental Pancreatic Cystic Lesions |
| Q38926583 | Management of Mixed-Type Intraductal Papillary Mucinous Neoplasm |
| Q26777379 | Molecular detection of pancreatic neoplasia: Current status and future promise |
| Q38143609 | Molecular diagnostics of pancreatic cysts |
| Q53286092 | Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas. |
| Q36609351 | Natural history of asymptomatic pancreatic cystic neoplasms. |
| Q41690551 | Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct |
| Q38757526 | Novel Biomarkers for Pancreatic Cysts |
| Q92462626 | Observation or resection of pancreatic intraductal papillary mucinous neoplasm: An ongoing tug of war |
| Q39426186 | Outcome of long interval radiological surveillance of side branch pancreatic duct-involved intraductal papillary mucinous neoplasm in selected patients |
| Q93184522 | Overview and comparison of guidelines for management of pancreatic cystic neoplasms |
| Q39320253 | Pancreatic Cysts and Guidelines |
| Q33353791 | Pancreatic cystic lesions: How endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle |
| Q57494392 | Pancreatic cystic neoplasms in 2018: The final cut |
| Q34179171 | Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas |
| Q39341924 | Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study |
| Q38370152 | Predictive factors for surgery among patients with pancreatic cysts in the absence of high-risk features for malignancy |
| Q36872788 | Preoperative classification of pancreatic cystic neoplasms: the clinical significance of diagnostic inaccuracy |
| Q26783953 | Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions |
| Q37634503 | Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer. |
| Q37699125 | Quantitative imaging to evaluate malignant potential of IPMNs |
| Q57767486 | RE: Proteomic Mucin Profiling for the Identification of Cystic Precursors of Pancreatic Cancer |
| Q35178284 | Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development |
| Q53618459 | Research gaps in pancreatic cancer research and comparative effectiveness research methodologies. |
| Q38161946 | Role of endoscopic ultrasonography in pancreatic cystic neoplasms: where do we stand and where will we go? |
| Q42618958 | Screening for pancreatic cancer: what can cyst fluid analysis tell us? |
| Q38425475 | Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). |
| Q38525151 | Systematic Review of Pancreatic Cyst Fluid Biomarkers: The Path Forward |
| Q53449646 | The Conundrum of Pancreatic Cysts: Are We Finally Moving the (EUS) Needle? |
| Q33858586 | The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? |
| Q36097201 | The value of cyst fluid analysis in the pre-operative evaluation of pancreatic cysts |
| Q90641168 | Tuberculosis presenting as a pancreatic cystic neoplasm |
| Q47174130 | Vanishing Pancreatic Cysts during Follow-Up: Another Step Towards De-Emphasizing Cyst Size as a Major Clinical Predictor of Malignancy |
| Q57640756 | [Branch duct intraductal papillary mucinous neoplasm - contra resection] |
| Q52984214 | [Ductal adenocarcinoma and unusual differential diagnosis]. |
| Q53179014 | [Surgical therapy of intraductal papillary mucinous neoplasms of the pancreas]. |
| Q36541286 | miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts |
Search more.